1
|
Gonzatti MB, Júnior JEM, Rocha AJ, de Oliveira JS, Evangelista AJDJ, Fonseca FMP, Ceccatto VM, de Oliveira AC, da Cruz Freire JE. Mechanism of molecular interaction of sitagliptin with human DPP 4 enzyme - New Insights. Adv Med Sci 2023; 68:402-408. [PMID: 37837799 DOI: 10.1016/j.advms.2023.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 06/16/2023] [Accepted: 10/04/2023] [Indexed: 10/16/2023]
Abstract
PURPOSE Dipeptidyl peptidase 4 (DPP4) inactivates a range of bioactive peptides. The cleavage of insulinotropic peptides and glucagon-like peptide 1 (GLP1) by DPP4 directly influences glucose homeostasis. This study aimed to describe the mode of interaction between sitagliptin (an antidiabetic drug) and human DPP4 using in silico approaches. MATERIALS AND METHODS Docking studies were conducted using AutoDock Vina, 2D and 3D schematic drawings were obtained using PoseView and PLIP servers, and the DPP4-sitagliptin complex was visualized with Pymol software. RESULTS The best affinity energy to form the DPP4-sitagliptin complex was E-value = - 8.1 kcal mol-1, as indicated by docking simulations. This result suggests a strong interaction. According to our observations, hydrophobic interactions involving the amino acids residues Tyr663 and Val712, hydrogen bonds (Glu203, Glu204, Tyr663, and Tyr667), π-Stacking interactions (Phe355 and Tyr667), and halogenic bonds (Arg123, Glu204, and Arg356) were prevalent in the DPP4-sitagliptin complex. Root Mean Square Deviation prediction also demonstrated that the global structure of the human DPP4 did not have a significant change in its topology, even after the formation of the DPP4-sitagliptin complex. CONCLUSION The stable interaction between the sitagliptin ligand and the DPP4 enzyme was demonstrated through molecular docking simulations. The findings presented in this work enhance the understanding of the physicochemical properties of the sitagliptin interaction site, supporting the design of more efficient gliptin-like iDPP4 inhibitors.
Collapse
Affiliation(s)
| | | | - Antônio José Rocha
- Department of Genetics, Evolution, Immunology, and Microbiology, State University of Campinas, Campinas, SP, Brazil
| | | | | | - Fátima Morgana Pio Fonseca
- Department of Microbiology, Immunology, and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil
| | | | | | | |
Collapse
|
2
|
Gaudêncio SP, Pereira F. Marine Drug Discovery through Computer-Aided Approaches. Mar Drugs 2023; 21:452. [PMID: 37623733 PMCID: PMC10456492 DOI: 10.3390/md21080452] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Accepted: 08/16/2023] [Indexed: 08/26/2023] Open
Abstract
Besides the importance of our oceans as oxygen factories, food providers, shipping pathways, and tourism enablers, oceans hide an unprecedented wealth of opportunities [...].
Collapse
Affiliation(s)
- Susana P. Gaudêncio
- Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA Faculty of Sciences and Technology, NOVA University of Lisbon, 2819-516 Lisbon, Portugal
- UCIBIO, Applied Molecular Biosciences Unit, Chemistry Department, NOVA Faculty of Sciences and Technology, NOVA University of Lisbon, 2819-516 Lisbon, Portugal
| | - Florbela Pereira
- LAQV, Chemistry Department, NOVA Faculty of Sciences and Technology, NOVA University of Lisbon, 2819-516 Lisbon, Portugal;
| |
Collapse
|
3
|
Wang H, Yang L, Chao J. Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats. Front Endocrinol (Lausanne) 2022; 13:932488. [PMID: 36060953 PMCID: PMC9437630 DOI: 10.3389/fendo.2022.932488] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Accepted: 06/27/2022] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Glucocorticoids (GCs) induce osteoporosis, which results in fractures in the bond, causing significant morbidity. In the conducted study, we examined the antiosteoporosis effect of dieckol against GC-induced osteoporosis in rats. METHODS Sprague-Dawley (SD) rats were used for the current study and dexamethasone (2.5 mg/kg) induced osteoporosis in the rats that received the dieckol (test) and alendronate (standard) for 20 weeks. Bone turnover parameters, microCT, antioxidant, inflammatory cytokines, nutrient, and hormones parameters. RESULTS Dieckol noticeably suppressed the body weight and boosted the uterine and vagina weight. Dieckol considerably altered the level of trabecular number (Tb. N), the bone volume to total volume (BV/TV), trabecular separation (Tb.Sp), bone surface to bone volume (BS/BV), and trabecular thickness (Tb.Th). Dieckol noticeably (P < 0.001) elevated the level of osteocalcin (OC) and alleviated the level of bone Gla protein (BGP), acid phosphatase (ACP), alkaline phosphatase (ALP), and β-CTx. Dieckol markedly boosted the level of malondialdehyde (MDA) and suppressed the level of glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD) along with the suppression of inflammatory cytokines like TNF-α, IL-1β, and IL-6. Dieckol remarkably increased the level of calcium, potassium, magnesium, and 25 (OH) vitamin D. Dieckol substantially (P < 0.001) boosted the level of estradiol and alleviated the level of parathyroid hormone and tartrate-resistant acid phosphatase (TRAP). Dieckol also suppressed the level of receptor activator of nuclear factor κB ligand (RANKL) and boosted the level of osteoprotegerin (OPG). CONCLUSION Taken together, our data suggest that dieckol demonstrated the anti-osteoporosis effect against GC-induced osteoporosis in rats.
Collapse
|
4
|
Prajapati R, Seong SH, Paudel P, Park SE, Jung HA, Choi JS. In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and D 2L and D 4 Receptor Agonist. ACS OMEGA 2021; 6:33443-33453. [PMID: 34926894 PMCID: PMC8674921 DOI: 10.1021/acsomega.1c04109] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Accepted: 11/24/2021] [Indexed: 06/14/2023]
Abstract
Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine D1R, D2LR, D3R, and D4R, vasopressin V1AR, and serotonin 5-HT1AR are noted in various neurodegenerative diseases (NDDs). Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition of monoamine oxidases (hMAOs), our study explored the functional role of kurarinone, an abundant lavandulated flavonoid in Sophora flavescens, on dopamine receptor subtypes, V1AR, 5-HT1AR, and hMAOs. Radioligand binding assays revealed considerable binding of kurarinone on D1R, D2LR, and D4R. Functional GPCR assays unfolded the compound's antagonist behavior on D1R (IC50 42.1 ± 0.35 μM) and agonist effect on D2LR and D4R (EC50 22.4 ± 3.46 and 71.3 ± 4.94 μM, respectively). Kurarinone was found to inhibit hMAO isoenzymes in a modest and nonspecific manner. Molecular docking displayed low binding energies during the intermolecular interactions of kurarinone with the key residues of the deep orthosteric binding pocket and the extracellular loops of D1R, D2LR, and D4R, validating substantial binding affinities to these prime targets. With appreciable D2LR and D4R agonism and D1R antagonism, kurarinone might be a potential compound that can alleviate clinical symptoms of Parkinson's disease and other NDDs.
Collapse
Affiliation(s)
- Ritu Prajapati
- Department
of Food and Life Science, Pukyong National
University, Busan 48513, Republic of Korea
| | - Su Hui Seong
- Department
of Food and Life Science, Pukyong National
University, Busan 48513, Republic of Korea
- Natural
Products Research Division, Honam National
Institute of Biological Resource, Mokpo 58762, Republic
of Korea
| | - Pradeep Paudel
- Department
of Food and Life Science, Pukyong National
University, Busan 48513, Republic of Korea
- National
Center for Natural Products Research, The
University of Mississippi, Oxford, Mississippi 38677, United States
| | - Se Eun Park
- Department
of Food and Life Science, Pukyong National
University, Busan 48513, Republic of Korea
- Department
of Biomedical Science, Asan Medical Institute
of Convergence Science and Technology, Seoul 05505, Republic
of Korea
| | - Hyun Ah Jung
- Department
of Food Science and Human Nutrition, Jeonbuk
National University, Jeonju 54896, Republic of Korea
| | - Jae Sue Choi
- Department
of Food and Life Science, Pukyong National
University, Busan 48513, Republic of Korea
| |
Collapse
|
5
|
Prajapati R, Seong SH, Park SE, Paudel P, Jung HA, Choi JS. Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D 1, D 3, and vasopressin V 1A receptors. Sci Rep 2021; 11:23528. [PMID: 34876600 PMCID: PMC8651714 DOI: 10.1038/s41598-021-02843-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Accepted: 11/18/2021] [Indexed: 01/15/2023] Open
Abstract
Isoliquiritigenin (= 4,2′,4′-Trihydroxychalcone) (ILG) is a major constituent of the Glycyrrhizae Rhizoma that has significant neuroprotective functions. In the present study, we re-examined the potential of ILG to inhibit human monoamine oxidase (hMAO) in vitro and established its mechanism of inhibition through a kinetics study and molecular docking examination. ILG showed competitive inhibition of hMAO-A and mixed inhibition of hMAO-B with IC50 values of 0.68 and 0.33 µM, respectively, which varied slightly from the reported IC50 values. Since ILG has been reported to reduce dopaminergic neurodegeneration and psychostimulant-induced toxicity (both of which are related to dopamine and vasopressin receptors), we investigated the binding affinity and modulatory functions of ILG on dopamine and vasopressin receptors. ILG was explored as an antagonist of the D1 receptor and an agonist of the D3 and V1A receptors with good potency. An in silico docking investigation revealed that ILG can interact with active site residues at target receptors with low binding energies. These activities of ILG on hMAO and brain receptors suggest the potential role of the compound to ameliorate dopaminergic deficits, depression, anxiety, and associated symptoms in Parkinson’s disease and other neuronal disorders.
Collapse
Affiliation(s)
- Ritu Prajapati
- Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea
| | - Su Hui Seong
- Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea.,Division of Natural Products Research, Honam National Institute of Biological Resource, Mokpo, 58762, Republic of Korea
| | - Se Eun Park
- Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea.,Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Seoul, 05505, Republic of Korea
| | - Pradeep Paudel
- Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea.,National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, The University of Mississippi, Oxford, MS, 38677, USA
| | - Hyun Ah Jung
- Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
| | - Jae Sue Choi
- Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea.
| |
Collapse
|
6
|
Woo H, Kim MK, Park S, Han SH, Shin HC, Kim BG, Oh SH, Suh MW, Lee JH, Park MK. Effect of Phlorofucofuroeckol A and Dieckol Extracted from Ecklonia cava on Noise-induced Hearing Loss in a Mouse Model. Mar Drugs 2021; 19:443. [PMID: 34436282 PMCID: PMC8400186 DOI: 10.3390/md19080443] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 07/23/2021] [Accepted: 07/28/2021] [Indexed: 12/20/2022] Open
Abstract
One of the well-known causes of hearing loss is noise. Approximately 31.1% of Americans between the ages of 20 and 69 years (61.1 million people) have high-frequency hearing loss associated with noise exposure. In addition, recurrent noise exposure can accelerate age-related hearing loss. Phlorofucofuroeckol A (PFF-A) and dieckol, polyphenols extracted from the brown alga Ecklonia cava, are potent antioxidant agents. In this study, we investigated the effect of PFF-A and dieckol on the consequences of noise exposure in mice. In 1,1-diphenyl-2-picrylhydrazyl assay, dieckol and PFF-A both showed significant radical-scavenging activity. The mice were exposed to 115 dB SPL of noise one single time for 2 h. Auditory brainstem response(ABR) threshold shifts 4 h after 4 kHz noise exposure in mice that received dieckol were significantly lower than those in the saline with noise group. The high-PFF-A group showed a lower threshold shift at click and 16 kHz 1 day after noise exposure than the control group. The high-PFF-A group also showed higher hair cell survival than in the control at 3 days after exposure in the apical turn. These results suggest that noise-induced hair cell damage in cochlear and the ABR threshold shift can be alleviated by dieckol and PFF-A in the mouse. Derivatives of these compounds may be applied to individuals who are inevitably exposed to noise, contributing to the prevention of noise-induced hearing loss with a low probability of adverse effects.
Collapse
Affiliation(s)
- Hyunjun Woo
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
| | - Min-Kyung Kim
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
| | - Sohyeon Park
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
- Interdisciplinary Program in Neuroscience, College of Natural Sciences, Seoul National University, Seoul 08826, Korea
| | - Seung-Hee Han
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
| | - Hyeon-Cheol Shin
- CEWIT Center for Systems Biology, State University of New York, Incheon 21985, Korea;
| | - Byeong-gon Kim
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
- Sensory Organ Research Institute, Medical Research Center, Seoul National University, Seoul 03080, Korea
| | - Seung-Ha Oh
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
- Sensory Organ Research Institute, Medical Research Center, Seoul National University, Seoul 03080, Korea
| | - Myung-Whan Suh
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
| | - Jun-Ho Lee
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
- Sensory Organ Research Institute, Medical Research Center, Seoul National University, Seoul 03080, Korea
| | - Moo-Kyun Park
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea; (H.W.); (M.-K.K.); (S.P.); (S.-H.H.); (B.-g.K.); (S.-H.O.); (M.-W.S.); (J.-H.L.)
- Sensory Organ Research Institute, Medical Research Center, Seoul National University, Seoul 03080, Korea
- Wide River Institute of Immunology, College of Medicine, Seoul National University, Hongcheon 25159, Korea
| |
Collapse
|